Abstract
Background
99mTc-labeled teboroxime shows high myocardial extraction in both in vivo animal and in vitro cell culture and isolated heart studies. Whereas in vivo studies show rapid myocardial clearance of teboroxime, in vitro cell culture and isolated heart studies show slower washout comparable to that of201Tl. Binding of teboroxime to blood components may contribute to these conflicting results.
Methods and Results
We measured teboroxime extraction in the isolated blood-perfused rabbit heart after injection in saline solution, brief incubation in red blood cell perfusate, or 4-hour incubation with human red blood cells. Teboroxime in saline solution showed high extraction (Emax=0.89±0.02; Enet=0.69±0.02), whereas brief incubation in perfusate (Emax=0.60±0.06; Enet=0.48±0.05) or prolonged incubation with human red blood cells (Emax=0.43±0.09; Ene=0.38±0.07) resulted in reduced extraction. Teboroxime clearance was similar for all groups and was slower than201Tl clearance. Analysis of total residual cardiac teboroxime (comparable to external imaging) showed that teboroxime clearance was biexponential. Reduced extraction of teboroxime in red blood cells resulted in an increased size of the rapidly clearing (unextracted) fraction, giving the appearance of rapid myocardial washout.
Conclusions
Teboroxime has a high myocardial extraction. Binding to blood components reduces teboroxime extraction and increases the rate of cardiac teboroxime clearance.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Kronauge JF, Chiu ML, Cone JS, et al. Comparison of neutral and cationic myocardial perfusion agents: characteristics of accumulation in cultured cells. Nucl Med Biol 1992;19:141–8.
Maublant JC, Moins N, Gachon P. Uptake and release of two new Tc-99m labeled myocardial blood flow imaging agents in cultured cardiac cells. Eur J Nucl Med 1989;15:180–2.
Leppo JA, Meerdink DJ. Comparative myocardial extraction of two technetium-labeled BATO derivatives (SQ30217, SQ32014) and thallium. J Nucl Med 1990;31:67–74.
Gray WA, Gewirtz H. Comparison of99mTc-teboroxime with thallium for myocardial imaging in the presence of a coronary artery stenosis. Circulation 1991;84:1796–807.
Beanlands R, Muzik O, Nguyen N, Petry N, Schwaiger M. The relationship between myocardial retention of technetium-99m teboroxime and myocardial blood flow. J Am Coll Cardiol 1992;20:712–9.
Stewart RE, Schwaiger M, Hutchins GD, et al. Myocardial clearance kinetics of technetium-99m-Q30217: a marker of regional myocardial blood flow. J Nucl Med 1990;31:1183–90.
Stewart RE, Heyl B, O’Rourke RA, Blumhardt R, Miller DD. Demonstration of differential post-stenotic myocardial technetium-99m-teboroxime clearance kinetics after experimental ischemia and hyperemic stress. J Nucl Med 1991;32:2000–8.
Johnson G III, Glover DK, Hebert CB, Okada RD. Early myocardial clearance kinetics of technetium-99m-teboroxime differentiate normal and flow-restricted canine myocardium at rest. J Nucl Med 1993;34:630–6.
Marshall RC, Leidholdt EM Jr, Zhang D-Y, Barnett CA. The effect of flow on technetium-99m-teboroxime (SQ30217) and thallium-201 extraction and retention in rabbit heart. J Nucl Med 1991;32:1979–88.
Deutsch E, Ketring AR, Libson K, Vanderheyden J-L, Hirth WW. The Noah’s ark experiment: species dependent biodistributions of cationic99mTc complexes. Nucl Med Biol 1989;16:191–232.
Gerundini P, Savi A, Gilardi MC, et al. Evaluation in dogs and humans of three potential technetium-99m myocardial perfusion agents. J Nucl Med 1986;27:409–16.
Dahlberg ST, Gilmore MP, Siwko R, Leppo JA. Incubation with red blood cells reduces the extraction of technetium-99m teboroxime in the isolated rabbit heart [Abstract]. J Nucl Med 1991;32:910.
Narra RK, Nunn AD, Kuczynski BL, Feld T, Wedeking P, Eckelman WC. A neutral technetium-99m complex for myocardial imaging. J Nucl Med 1989;30:1830–7.
Leppo JA, Meerdink DJ. Comparison of the myocardial uptake of a technetium-labeled isonitrile analogue and thallium. Circ Res 1989;65:632–9.
Hnatowich DJ, Layne WD, Childs RL. The preparation and labeling of DTPA-coupled albumin. Int J Appl Radiat Isot 1982;33:327–32.
Marshall RC, Leidholdt EM Jr, Zhang D-Y, Barnett CA. Technetium-99m hexakis 2-methoxy-2-isobutyl isonitrile and thallium-201 extraction, washout and retention at varying coronary flow rates in rabbit heart. Circulation 1990;82:998–1007.
Bassingthwaighte JB, Holloway GA. Estimation of blood flow with radioactive tracers. Semin Nucl Med 1976;6:141–61.
Bassingthwaighte JB, Raymond GM, Chan JI. Principles of tracer kinetics. In: Zaret BL, Beller GA, eds. Nuclear cardiology: state of the art and future directions. St Louis: Mosby-Year Book, 1993:3–23.
Kuikka JT, Bassingthwaighte JB, Henrich MM, Feinendegen Le. Mathematical modeling in nuclear medicine. Eur J Nucl Med 1991;18:351–62.
Bassingthwaighte JB, Goresky CA. Modeling in the analysis of solute and water exchange in the microvasculature. In: Renkin EM, Michel CC, eds. Handbook of physiology: the cardiovascular system, vol 4: the microcirculation. Bethesda, Maryland: American Physiological Society, 1984:549–626.
Bassingthwaighte JB. Physiology and theory of tracer washout techniques for the estimation of myocardial blood flow: flow estimation from tracer washout. Prog Cardiovasc Dis 1977;20:165–89.
Bassingthwaighte JB, Chinard FP, Crone C, et al. Terminology for mass transport and exchange. Am J Physiol 1986;250:H539–45.
Weich HF, Strauss HW, Pitt B. The extraction of thallium-201 by the myocardium. Circulation 1977;56:188–91.
Grunwald AM, Watson DD, Holzgrefe HH Jr, Irving JF, Beller GA. Myocardial thallium-201 kinetics in normal and ischemic myocardium. Circulation 1981;64:610–8.
Rumsey WL, Rosenspire KC, Nunn AD. Myocardial extraction of teboroxime: effects of teboroxime interaction with blood. J Nucl Med 1992;33:94–101.
McCall D, Zimmer LJ, Katz AM. Kinetics of thallium exchange in cultured rat myocardial cells. Circ Res 1985;56:370–6.
Stone JA, Dawood F, Wen W-H, McLaughlin PR, Liu PP. Is the myocardial uptake of teboroxime viability dependent? [Abstract]. Circulation 1992;86:I-707.
Beanlands RS, Palser A, Hartman N, Aung M, Ruddy TD. Are the kinetics of Tc-99m-teboroxime altered in the postischemic myocardium? (Abstract). Circulation 1993;88:249.
Okada RD, Jacobs ML, Daggett WM, et al. Thallium-201 kinetics in nonischemic canine myocardium. Circulation 1982;65:70–7.
Gewirtz H. Differential myocardial washout of technetium-99m-teboroxime: mechanism and significance. J Nucl Med 1991;32:2009–11.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dahlberg, S.T., Gilmore, M.P. & Leppo, J.A. Interaction of technetium 99m-labeled teboroxime with red blood cells reduces the compound’s extraction and increases apparent cardiac washout. J. Nucl. Cardiol. 1, 270–279 (1994). https://doi.org/10.1007/BF02940341
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02940341